MLYS MINERALYS THERAPEUTICS INC

Ownership history in FEDERATED HERMES, INC.  ·  10 quarters on record

This page tracks every 13F SEC filing in which FEDERATED HERMES, INC. reported a position in MINERALYS THERAPEUTICS INC (MLYS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 21 -16,507 -99.9% 0.00% $796 $37.92
2025 Q2 ADDED 16,528 +4,577 +38.3% 0.00% $224K $13.53
2025 Q1 REDUCED 11,951 -3,565 -23.0% 0.00% $190K $15.88
2024 Q4 REDUCED 15,516 -1,332 -7.9% 0.00% $191K $12.31
2024 Q3 ADDED 16,848 +4,848 +40.4% 0.00% $204K $12.11
2024 Q2 ADDED 12,000 +6,000 +100.0% 0.00% $140K $11.70
2024 Q1 REDUCED 6,000 -14,032 -70.0% 0.00% $77K $12.91
2023 Q4 REDUCED 20,032 -2,261 -10.1% 0.00% $172K $8.60
2023 Q3 ADDED 22,293 +1,700 +8.3% 0.00% $212K $9.51
2023 Q2 INITIATED 20,593 0.00% $351K $17.05
% of Fund (quarterly)    MLYS price (monthly, adj. close)
← Back to FEDERATED HERMES, INC. Holdings